Toxicology Laboratory at UC San Diego School of Medicine Joins Center of Innovation Program

Mass spectrometry & spectroscopy

Toxicology Laboratory at UC San Diego School of Medicine Joins Center of Innovation Program

20 Apr, 2016

Published over 10 years ago. See the latest and most current information on Mass spectrometry & spectroscopy.

At a ceremony at the University of California San Diego School of Medicine, Waters Corporation officially welcomed the university’s Center for Advanced Laboratory Medicine into the Waters Centers of Innovation (COI) Program. Under the direction of Professor Robert Fitzgerald, Director of Toxicology and Associate Director of Clinical Chemistry, the laboratory develops, validates and implements liquid chromatography-mass spectrometry (LC-MS) diagnostic tests, including broad spectrum screens for drugs of abuse, therapeutic drug monitoring and vitamin D testing.

”We are very excited that Waters Corporation has recognised our department’s work in developing mass spectrometry-based tests for the clinical laboratory,” said Dr Steven L. Gonias, Chair of the Department of Pathology in the UC San Diego School of Medicine and Chief of Pathology, at UC San Diego Health. “Dr Fitzgerald and Dr David Herold of the UC San Diego School of Medicine have contributed landmark studies focused on improving the accuracy of diagnostic tests by applying mass spectrometry in new and innovative ways. The potential to further improve patient care through the expanded use of mass spectrometry is indeed impressive.”

In his role, Dr Fitzgerald oversees the activities of three clinical laboratories for UC San Diego Health which together perform more than 4.5 million assays annually. Dr Fitzgerald’s laboratory utilises several Waters tandem quadrupole and quadrupole time of flight mass spectrometers, including the Xevo® TQ-S, Xevo G2 QTof™ and ACQUITY®TQD.

“Waters has been an outstanding partner for us and has fully supported us with robust instrumentation and solid technical support,” Dr Fitzgerald said. “I am particularly excited about the aspect of our collaboration with Waters that allows us to train the next generation of leaders in clinical chemistry, a field in which mass spectrometry is becoming increasingly important.”

“It’s a pleasure to welcome the UC San Diego School of Medicine into our COI Program. Largely due to the efforts of scientists like Dr Fitzgerald and his colleagues, the value of LC and MS in the clinical laboratory has been clearly proven and is having lasting benefits in the clinic,” said Eric Fotheringham, Director of the Waters Centers of Innovation Program.

To salute the work of Professor Fitzgerald and the Center for Advanced Laboratory Medicine, Waters Corporation is sponsoring a clinical science symposium. Titled Mass Spectrometry in the Modern Clinical Laboratory, the event features presentations by noted experts in clinical chemistry. 

Latest News

LMUK 51.7 Nov 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Phenol on the ground: what a COMAH prosecution shows about soil data as evidence
Explore more Arrow
Pollution Solutions Online
Pump and mixer service at paper mill set to reach 40 years
Explore more Arrow
Petro Online
Hydrogen sulphide deaths expose the gaps in gas detection during non-routine work
Explore more Arrow
Chromatography Today
High-load peptide purification
Explore more Arrow